sign in
sign in
register
Rules
Sign in with Facebook
Sign in with Linkedin
Remember me
INVESTORS
My Home
Small Cap Marketplace
Broadcast Center
Request New Hub
Quick Tips
Ratings & Ranks
PUBLIC COMPANIES
Investor Relations
Success Stories
Clients
Testimonials
Contact
Conferences
About us
A revenue-generating, small-cap Canadian pharmaceutical company
Revenue Projected at $150,000,000 by 2025
Discussion Forum: Valeo Pharma Inc.
List Message View
Thread Message View
New Message
Author / Date /
Topic Title
Rating
Re
Last Post
AGORACOM-KE - Mar 15, 2022 06:05PM
AGORACOM Small Cap 60: Was A Record Year, Valeo Pharma (VPH: CSE) Management Is Never Satisfied
1
amirasamy9
Mar 16, 2022 05:41AM
AGORACOM-KE - Mar 15, 2022 12:19PM
AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Had Record Revenues in 2021 of $13.6 Million, Up 81% Over 2020
0
AGORACOM-KE
Mar 15, 2022 12:19PM
AGORACOM-KE - Mar 11, 2022 06:35PM
AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Is Engaged In High-Level Business Development
0
AGORACOM-KE
Mar 11, 2022 06:35PM
AGORACOM-KE - Mar 11, 2022 10:27AM
AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Reports Record Annual Revenues For Fiscal 2021
0
AGORACOM-KE
Mar 11, 2022 10:27AM
AGORACOM-KE - Mar 06, 2022 07:48PM
VIDEO - Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Hits Record Annual Revenues Of $13.6 MILLION … Targeting $150 MILLION By 2025
0
AGORACOM-KE
Mar 06, 2022 07:33PM
AGORACOM - Mar 03, 2022 05:31PM
INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)
0
AGORACOM
Mar 03, 2022 05:31PM
AGORACOM-KE - Mar 01, 2022 08:47PM
VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL 2021
0
AGORACOM-KE
Feb 28, 2022 08:47PM
AGORACOM-KE - Feb 24, 2022 08:34AM
Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® And Atectura® Breezhaler® In Ontario, Manitoba And New Brunswick
0
AGORACOM-KE
Feb 24, 2022 08:34AM
AGORACOM-KE - Feb 21, 2022 07:00AM
VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2021 RESULTS CONFERENCE CALL / WEBCAST
0
AGORACOM-KE
Feb 21, 2022 07:00AM
AGORACOM-KE - Feb 04, 2022 05:43PM
AGORACOM SmalCap 60: Valeo Pharma Aims To Build a First-Rate Top-Tier Canadian Company
0
AGORACOM-KE
Feb 04, 2022 05:43PM
AGORACOM-KE - Feb 04, 2022 11:41AM
AGORACOM Small Cap 60: Are More Nationwide Retailers Coming For Valeo Pharma Immune Booster
0
AGORACOM-KE
Feb 04, 2022 11:41AM
AGORACOM-KE - Jan 28, 2022 10:17AM
AGORACOM Small Cap 60: Valeo Pharma is very encouraged by immune booster
0
AGORACOM-KE
Jan 28, 2022 10:17AM
AGORACOM - Jan 20, 2022 02:14PM
AGORACOM Small Cap 60: Main Ingredient of Valeo Pharma’s Immune Booster Has Been Well Documented In Numerous Scientific Publications
0
AGORACOM
Jan 20, 2022 02:14PM
AGORACOM - Jan 18, 2022 10:58AM
AGORACOM Small Cap 60: Clinical study of Valeo Immune Booster Yields Encouraging Results, May Help Reduce COVID-19 Associated Symptoms
0
AGORACOM
Jan 18, 2022 10:58AM
AGORACOM-KE - Jan 14, 2022 04:16PM
AGORACOM Small Cap 60: Valeo Pharma Immune booster now available in 300 stores under Loblaws banners
0
AGORACOM-KE
Jan 14, 2022 04:16PM
AGORACOM-KE - Jan 12, 2022 04:31PM
AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Commercializes Drugs from other Parts of the World
0
AGORACOM-KE
Jan 12, 2022 04:31PM
AGORACOM - Jan 05, 2023 05:54PM
VIDEO – Valeo Pharma Immune Booster Now Available In ~300 Stores Under Loblaws Banner, Another Step Closer to 2025 Revenue Target of $160M
0
AGORACOM
Jan 06, 2022 08:25AM
AGORACOM-KE - Jan 05, 2022 07:00AM
Valeo Pharma's Hesperco™ Now Available At Loblaws, Hesperidin Covid-19 Clinical Trial Results Submitted For Publication
0
AGORACOM-KE
Jan 05, 2022 07:00AM
AGORACOM - Dec 17, 2021 04:28PM
VIDEO – Valeo Pharma Obtains Public Reimbursement For Asthma Drugs In Quebec and Nova Scotia, Another Step Closer to 2025 Revenue Target of $160M
0
AGORACOM
Dec 17, 2021 04:28PM
AGORACOM-KE - Dec 17, 2021 01:49PM
INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)
0
AGORACOM-KE
Dec 17, 2021 01:49PM
New Message
Log in to Agoracom
Sign in with Facebook
Sign in with Linkedin
Remember me